Memantine unproven to provide any clinical benefit in cases of vascular cognitive impairment

Authors

Irene Kitromelides, Wayne State University School of MedicineFollow

Abstract

A critical appraisal and clinical application of Wilcock G, Möbius HJ, Stöffler A. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol. 2002 Nov;17(6):297-305. doi: 10.1097/00004850-200211000-00005.

DOI

10.22237/crp/1549411260

Recommended Citation

KITROMELIDES I. Memantine unproven to provide any clinical benefit in cases of vascular cognitive impairment. Clin. Res. Prac. 2019 Feb 6;5(1):eP1642. doi: 10.22237/crp/1549411260